Skip to content

Clinical trials

Completed Phase 3 Arterial Occlusive Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Arterial Occlusive Diseases Phase: Phase 3 Status: Completed Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20043
20051
20091
20111
20171
20181
20192

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Northland Biotech. Co., Ltd.2
Boston Scientific Corporation2
National Heart, Lung, and Blood Institute (NHLBI)2
ARCA Biopharma, Inc.1
Amarin Pharma Inc.1
GE Healthcare1
Hermina Heart Center Kemayoran1
Johns Hopkins University1
Radboud University Medical Center1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Arterial Occlusive Diseases13
Heart Diseases4
Cardiovascular Diseases3
Coronary Artery Disease3
Coronary Disease3
Intermittent Claudication3
Ischemia3
Myocardial Ischemia3
Vascular Diseases3
Arteriosclerosis2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.